Oligoprogressive Disease
Showing 26 - 50 of >10,000
Myxoid Liposarcoma Trial in Amsterdam (Surgery, Preoperative RT 36Gy, Preoperative RT 50Gy)
Recruiting
- Myxoid Liposarcoma
- Surgery
- +4 more
-
Amsterdam, NetherlandsThe Netherlands Cancer Institute
Aug 4, 2021
Pancreas Cancer, Lung Cancer, Renal Cancer Trial in Boston (MR-guided Linac)
Recruiting
- Pancreas Cancer
- +12 more
- MR-guided Linac
-
Boston, Massachusetts
- +1 more
Sep 21, 2021
Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)
Not yet recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- CP-506
- +2 more
- (no location specified)
Jun 23, 2022
Metastatic Renal Cell Carcinoma, Radiotherapy Trial in France (Steretactic radiotherapy, Pursuit of ongoing systemic treatment)
Recruiting
- Metastatic Renal Cell Carcinoma
- Radiotherapy
- Steretactic radiotherapy
- Pursuit of ongoing systemic treatment
-
Albi, France
- +17 more
Aug 9, 2022
Solid Tumor Spine Metastases Trial in Dublin (Radiation: image guided dose escalated SABR using a simultaneous integrated boost
Not yet recruiting
- Solid Tumor Spine Metastases
- Radiation: image guided dose escalated SABR using a simultaneous integrated boost (SIB)
-
Dublin, Ireland
- +1 more
Oct 16, 2023
Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))
Active, not recruiting
- Oligoprogressive Renal Cell Carcinoma
- Stereotactic ablative body radiation (SABR)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 28, 2022
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- +3 more
- Lutetium Lu-177 PNT2002
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022
Oligometastatic Disease Trial in Milan (radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost,
Recruiting
- Oligometastatic Disease
- radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost, respectively
-
Milan, MI, ItalySan Raffaele Scientific Institute
Dec 23, 2022
Lung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRT Trial in Shanghai (pemetrexed,cisplatin/carboplatin,bevacizumab,durvalumab,SBRT)
Not yet recruiting
- Lung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRT
-
Shanghai, Shanghai, ChinaFudan University shanghai cancer center
Aug 16, 2020
CIRCULATING MICRO-RNA AND AR-V7 MUTATIONAL STATUS IN METASTATIC
Unknown status
- D011471
- +4 more
- Periodic ARV7 and miRNA evaluation
-
Florence, ItalyAOU Careggi Radiation Oncology Unit
Dec 4, 2019
Patients With EGFR Mutated Lung Cancer
Unknown status
- Lung Neoplasms
-
Aarhus, DK, DenmarkAarhus University Hospital
Nov 8, 2019
Pompe Disease Trial in New York, Fairfax (biological, drug, other)
Not yet recruiting
- Pompe Disease
- Cipaglucosidase alfa
- +3 more
-
New York, New York
- +1 more
Nov 2, 2023
Chronic Rhinosinusitis Associated With Inflammatory Bowel
Not yet recruiting
- Intestinal Inflammation
- Rhinosinusitis
- Observational study
- (no location specified)
Nov 21, 2023
Oral Lichen Planus, Topical Sulfasalazine, Corticosteroids Trial in Cairo (sulfasalazine 500 MG, corticosteroids)
Active, not recruiting
- Oral Lichen Planus
- +2 more
- sulfasalazine 500 MG
- corticosteroids
-
Cairo, EgyptFaculty of Dentistry, Cairo University
Sep 23, 2023
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Crohn's Disease Trial (MR Enterography (MRE))
Not yet recruiting
- Crohn's Disease
- MR Enterography (MRE)
- (no location specified)
Nov 13, 2023
Gastroesophageal Reflux Disease Trial in Assiut (Nursing Teaching)
Not yet recruiting
- Gastroesophageal Reflux Disease
- Nursing Teaching
-
Assiut, EgyptFaculty of Nursing Assiut University
Jul 10, 2023
Patients With Von Hippel Lindau Disease
Not yet recruiting
- Von Hippel Lindau Disease
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2023
Diabetes Trial in Taipei (Observational study - registry)
Recruiting
- Diabetes Mellitus
- Observational study - registry
-
Taipei, TaiwanThe Diabetes Association of the Republic of China (Taiwan)
Nov 26, 2023
Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury Trial in Butler (Biophotonizer - a
Recruiting
- Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
- Biophotonizer - a Biophoton Generator
-
Butler, PennsylvaniaTesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001
Nov 27, 2023
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
Recruiting
- Fabry Disease
-
Rockville, Maryland
- +1 more
Sep 29, 2023
Patients With Cognitive and Behavioral Disorders
Not yet recruiting
- Behavioral Variant of Frontotemporal Disorder (bvFTD)
- +3 more
- Submission of the NEO-PI-3 questionnaire
- Submission of the Interpersonal Reactivity Index questionnaire (IRI)
- (no location specified)
Sep 29, 2023
Ergot Alkaloids in Treatment of Salivation in Parkinson's
Enrolling by invitation
- Main Heading (Descriptor) Terms
- Dihydroergot mesylate
-
Nanjing, Jiangsu, ChinaDihydroergot mesylate
Sep 6, 2023
MRI-markers to Monitor Small Vessel Disease Dynamics in
Recruiting
- Intracerebral Hemorrhage
- +2 more
- Combined 3- and 7 Tesla-MRI
-
Bern, SwitzerlandDepartment of Neurology, Inselspital Bern University Hospital
Mar 6, 2023
Type 2 Diabetes, Hypertension Trial in Ibadan (Educational intervention)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Hypertension
- Educational intervention
-
Ibadan, Oyo, NigeriaDepartment of Clinical Pharmacy and Pharmacy Administration, Fac
Aug 14, 2023